infectious diseases

Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Endpoints
Vir Biotechnology
Harbor BioMed
cancer
infectious diseases
Flag link:
Here’s how Covid-19 has affected funding, development in infectious diseases
Here’s how Covid-19 has affected funding, development in infectious diseases
MedCity News
COVID-19
pandemic
infectious diseases
drug development
Flag link:
FDA Launches App for Reporting new Uses of Infectious Disease Drugs
FDA Launches App for Reporting new Uses of Infectious Disease Drugs
RAPS.org
FDA
infectious diseases
CURE ID
digital pharma
off-label
Flag link:
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
Researchers Call on FDA to Rethink Guidance Allowing Use of Surrogate Outcomes
RAPS.org
FDA
JAMA
infectious diseases
drug development
surrogate endpoints
Flag link:
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More
Xconomy
Vir Biotechnology
IPOs
infectious diseases
Flag link:
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs
Xconomy
Vir Biotechnology
IPOs
infectious diseases
Flag link:
Why Merck is in infectious disease for the long haul
Why Merck is in infectious disease for the long haul
BioCentury
Merck
R&D
infectious diseases
antibiotics
Flag link:
5 things to know about Hookipa Pharma ahead of its IPO
5 things to know about Hookipa Pharma ahead of its IPO
Marketwatch
Hookipa
IPOs
cancer
infectious diseases
Flag link:
Hookipa proposes IPO as its cancer vaccines head towards the clinic
Hookipa proposes IPO as its cancer vaccines head towards the clinic
BioCentury
Hookipa
IPOs
vaccines
cancer
infectious diseases
Flag link:
Researchers point to R&D treaty to spur new infectious disease treatments
Researchers point to R&D treaty to spur new infectious disease treatments
Endpoints
R&D
infectious diseases
Flag link:
ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments
ContraFect Corporation Prices $10 Million Public Offering of Common Stock to Develop Novel Infectious Disease Treatments
CP Wire
ContraFect
infectious diseases
Flag link:
Evotec seals deal for Sanofi’s infectious disease unit
Evotec seals deal for Sanofi’s infectious disease unit
Fierce Biotech
Evotec
Sanofi
M&A
infectious diseases
Flag link:
Allergan plans sales of women's health, infectious disease units
Allergan plans sales of women's health, infectious disease units
Reuters
Allergan
M&A
Women's Health
infectious diseases
Flag link:
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Merck Highlights Ongoing Commitment to Fighting Infectious Diseases with More than 30 Data Presentations at ID Week 2016
Yahoo
Merck
Zostavax
vaccines
infectious diseases
Zerbaxa
Flag link:
A New Index Measures Impact Pharma Has on Infectious Diseases
A New Index Measures Impact Pharma Has on Infectious Diseases
WSJ/Pharmalot
infectious diseases
Flag link:
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Riboxx Pharma collaborates with CNBG to evaluate potential of Riboxxim TLR3 agonist
Pharmaceutical Business Review
Riboxx
Riboxxim
China National Biotech Group
infectious diseases
Flag link:
ABC News Reports on Aethlon Medical
ABC News Reports on Aethlon Medical
Aethlon Medical
Hemopurifier
cancer
infectious diseases
Flag link:
FDA Clears Single-Use Antibacterial Surgical Respirator
FDA Clears Single-Use Antibacterial Surgical Respirator
FDA
surgical respirator
SpectraShield
infectious diseases
approvals
Flag link:
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
Aethlon Medical Discloses Part II of Emerging Opportunities in Biodefense Interview
Aethlon Medical
Aethlon Hemopurifier
infectious diseases
cancer
Flag link:
Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
Aethlon Medical
Aethlon Hemopurifier
India
infectious diseases
oncology
Flag link:

Pages